It’s not often a fish jumps into the boat for you! I feel embarrassed for you, but I shouldn’t, as clearly this is as close as it gets for you to speaking to a real person.
There’s no office in the USA, how have Cynata managed to recruit a patient over there??! That’s step one in your process, after all. I marked it down and you were still wrong.
If you actually trawled through MSB’s finances (spoiler alert: you didn’t), care to explain how they torched $230M USD to jab about 10 bums, while Cynata have spent about $20M to treat over 350 patients across the world?
P.S. we are in a rental crisis, so why are you allowing Sector to live in your head rent-free?
Ann: First Patient Treated in Phase 2 GvHD Trial, page-33
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.5¢ |
Change
-0.015(5.17%) |
Mkt cap ! $46.70M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 26.0¢ | $30.21K | 109.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 77107 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 33487 | 1 |
View Market Depth
| Last trade - 15.51pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
27.5¢ |
Change
-0.015 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 29.0¢ | 29.0¢ | 26.5¢ | 46774 | ||
| Last updated 15.51pm 21/05/2024 ? | |||||
| CYP (ASX) Chart |